Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010031/S931

Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome M

Medtronic Cardiac Rhythm Disease Management · Decision date Nov 4, 2026

FDA DECISIONP010031/S931

What did the FDA approve?

FDA records P010031/S931 as a supplement to PMA P010031, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Nov 4, 2026.

FDA approval order statement

approval for device labeling updates and change to nominal settings for Intrinsic Antitachycardia Pacing (iATP) feature in applicable Cobalt devices
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Nov 4, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P010031/S931
Regulatory pathway
PMA supplement
Product code
NIK
Decision code
APPR
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D).

Product code
NIK
FDA device class
3

For the original device and its historical approval scope, see PMA P010031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010031 · Original PMA

    CONCERTO/INSYNC SENTRY/INSYNC MAXIMO IMPLANTABLE CARDIOVASCULAR DEFIBRILLATORS WITH CARDIAC RESYNCHICNIZATION

  2. P010031/S931 received

    Application receipt date recorded by FDA.

  3. P010031/S932 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  4. P010031/S933 · Related supplement

    Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M

  5. P010031/S934 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  6. P010031/S931 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P010031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010031

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records